Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Eunuchism
- Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
- Natesto Spermatogenesis Reboot
- Testosterone Treatment in Men With Chronic Kidney Disease
- A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial
- Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
- The Effects of Natesto For Treatment Of Hypogonadism
- Vogelxo(R) ABPM Study in Hypogandal Men
- Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men
- A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism
- A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections
- Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
- Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
- Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes
- Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function
- Ambulatory Blood Pressure Monitoring in Oral Testosterone Undecanoate (TU, LPCN 1021) Treated Hypogonadal Men
- Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Obese Men With T2DM and Hypogonadism
- Study on Effects of Testosterone Replacement Therapy in Hypogonadal Type 2 Diabetic Patients" (SETH2)
- Testosterone-Dependent Effects on Protein Biomarkers From Healthy Males
- A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males
- Dosing Validation Study of Oral Testosterone Undecanoate (TU, LPCN 1021).
- Dosing Flexibility Study of Oral Testosterone Undecanoate (TU, LPCN 1021)
- Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters
- Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men
- Periodontal Profile of Hypogonadic Men
- Subcutaneous vs. Intramuscular Testosterone
- Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism
- Clomid in Men With Low Testosterone With and Without Prior Treatment
- Safety and Efficacy Trial of Testosterone Undecanoate
- Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism
- Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
- 5-Alpha Reductase and Anabolic Effects of Testosterone
- Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride
- 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men